Volume 21; Issue Supplement

Annals of Oncology

Volume 21; Issue Supplement
2

Osteosarcoma

Year:
2010
Language:
english
File:
PDF, 74 KB
english, 2010
5

Treatment of HER2-overexpressing breast cancer

Year:
2010
Language:
english
File:
PDF, 337 KB
english, 2010
7

Chronic lymphocytic leukemia

Year:
2010
Language:
english
File:
PDF, 118 KB
english, 2010
9

Advances in neuroendocrine lung tumors

Year:
2010
Language:
english
File:
PDF, 1.06 MB
english, 2010
12

Familial colorectal cancer risk: ESMO Clinical Practice Guidelines

Year:
2010
Language:
english
File:
PDF, 64 KB
english, 2010
15

BRCA in breast cancer: ESMO Clinical Practice Guidelines

Year:
2010
Language:
english
File:
PDF, 53 KB
english, 2010
16

The epithelial-mesenchymal transition (EMT) phenomenon

Year:
2010
Language:
english
File:
PDF, 59 KB
english, 2010
21

Histology-driven chemotherapy of soft-tissue sarcoma

Year:
2010
Language:
english
File:
PDF, 90 KB
english, 2010
23

Cancer of unknown primary site: 20 questions to be answered

Year:
2010
Language:
english
File:
PDF, 65 KB
english, 2010
26

Horizon scanning for novel therapeutics for the treatment of prostate cancer

Year:
2010
Language:
english
File:
PDF, 131 KB
english, 2010
27

Genetic counselling for hereditary predisposition to ovarian and breast cancer

Year:
2010
Language:
english
File:
PDF, 221 KB
english, 2010
28

Special Symposium: The use of biomarkers to guide treatment in hematological malignancies

Year:
2010
Language:
english
File:
PDF, 35 KB
english, 2010
29

Special Symposium: Targeting molecular pathways in the jungle of soft tissue sarcoma histology

Year:
2010
Language:
english
File:
PDF, 40 KB
english, 2010
30

Priorities for cancer control in Spain

Year:
2010
Language:
english
File:
PDF, 59 KB
english, 2010
31

Special Symposium: Targeted therapies in NSCLC: State-of-the-art and new developments

Year:
2010
Language:
english
File:
PDF, 48 KB
english, 2010
32

posters C: Preclinical drug profiles

Year:
2010
Language:
english
File:
PDF, 339 KB
english, 2010
33

ESMO Education

Year:
2010
Language:
english
File:
PDF, 39 KB
english, 2010
34

Hamilton fairley award

Year:
2010
Language:
english
File:
PDF, 22 KB
english, 2010
38

Introduction from the ESMO 2010 Educational Committee Chair

Year:
2010
Language:
english
File:
PDF, 20 KB
english, 2010
41

The role of human papillomavirus infection in head and neck cancers

Year:
2010
Language:
english
File:
PDF, 53 KB
english, 2010
42

loco-regional therapy

Year:
2010
Language:
english
File:
PDF, 73 KB
english, 2010
43

plenary session 3: Cancer stem cell targets

Year:
2010
Language:
english
File:
PDF, 46 KB
english, 2010
44

Cancer stem cells

Year:
2010
Language:
english
File:
PDF, 28 KB
english, 2010
45

Special Symposium: Toxicities of targeted therapies: Prevention and management

Year:
2010
Language:
english
File:
PDF, 32 KB
english, 2010
46

The European Society for Medical Oncology (ESMO)

Year:
2010
Language:
english
File:
PDF, 45 KB
english, 2010
48

Welcome to the IMPAKT 2010 Breast Cancer Conference

Year:
2010
Language:
english
File:
PDF, 17 KB
english, 2010
50

author index

Year:
2010
File:
PDF, 41 KB
2010
51

Supportive care

Year:
2010
Language:
english
File:
PDF, 400 KB
english, 2010
52

Melanoma

Year:
2010
Language:
english
File:
PDF, 123 KB
english, 2010
54

Multiple myeloma

Year:
2010
Language:
english
File:
PDF, 84 KB
english, 2010
55

abstracts

Year:
2010
Language:
english
File:
PDF, 34 KB
english, 2010
57

practice-changing discoveries in translational research

Year:
2010
Language:
english
File:
PDF, 29 KB
english, 2010
58

Psycho-oncology

Year:
2010
Language:
english
File:
PDF, 137 KB
english, 2010
59

Gastrointestinal tumors

Year:
2010
Language:
english
File:
PDF, 380 KB
english, 2010
60

plenary session 8: Drug development methodology & regulatory affairs

Year:
2010
Language:
english
File:
PDF, 25 KB
english, 2010
61

Management of cancer pain: ESMO Clinical Practice Guidelines

Year:
2010
Language:
english
File:
PDF, 58 KB
english, 2010
62

European Society for Medical Oncology Committees

Year:
2010
Language:
english
File:
PDF, 30 KB
english, 2010
64

Poster session 2

Year:
2010
Language:
english
File:
PDF, 163 KB
english, 2010
69

Introduction

Year:
2010
Language:
english
File:
PDF, 21 KB
english, 2010
70

Oral session 2

Year:
2010
Language:
english
File:
PDF, 87 KB
english, 2010
71

Neuro-oncology

Year:
2010
Language:
english
File:
PDF, 141 KB
english, 2010
72

Europa Donna

Year:
2010
Language:
english
File:
PDF, 41 KB
english, 2010
73

Anemia in cancer

Year:
2010
Language:
english
File:
PDF, 76 KB
english, 2010
74

Nasopharyngeal carcinoma

Year:
2010
Language:
english
File:
PDF, 63 KB
english, 2010
75

8th International Symposium on Targeted Anticancer Therapies (TAT 2010)

Year:
2010
Language:
english
File:
PDF, 17 KB
english, 2010
77

ESMO Clinical Practice Guidelines: development, implementation and dissemination

Year:
2010
Language:
english
File:
PDF, 41 KB
english, 2010
78

35th ESMO Congress Officers

Year:
2010
Language:
english
File:
PDF, 22 KB
english, 2010
80

Optimal treatment for relapsing ovarian cancer

Year:
2010
Language:
english
File:
PDF, 157 KB
english, 2010
81

35th ESMO Congress Officers

Year:
2010
Language:
english
File:
PDF, 28 KB
english, 2010
82

ESMO 2010 late-breaking abstracts

Year:
2010
Language:
english
File:
PDF, 205 KB
english, 2010
83

plenary session 10: Miscellaneous targets

Year:
2010
Language:
english
File:
PDF, 45 KB
english, 2010
87

Committees

Year:
2010
Language:
english
File:
PDF, 19 KB
english, 2010
88

35th ESMO Congress Organization

Year:
2010
Language:
english
File:
PDF, 70 KB
english, 2010
89

keynote lectures

Year:
2010
Language:
english
File:
PDF, 27 KB
english, 2010
91

Optimal treatment for recurrent/metastatic head and neck cancer

Year:
2010
Language:
english
File:
PDF, 108 KB
english, 2010
92

Poster session 1

Year:
2010
Language:
english
File:
PDF, 170 KB
english, 2010
93

Advances in systemic treatment of melanoma

Year:
2010
Language:
english
File:
PDF, 81 KB
english, 2010
94

Health services and public health

Year:
2010
Language:
english
File:
PDF, 195 KB
english, 2010
95

Guidelines Working Group Members

Year:
2010
File:
PDF, 106 KB
2010
96

plenary session 4: Cell signaling targets

Year:
2010
Language:
english
File:
PDF, 46 KB
english, 2010
99

New agents for bladder cancer

Year:
2010
Language:
english
File:
PDF, 52 KB
english, 2010
101

Merkel cell carcinoma

Year:
2010
Language:
english
File:
PDF, 71 KB
english, 2010
102

Chest tumors

Year:
2010
Language:
english
File:
PDF, 607 KB
english, 2010
103

ESMO Fellowship Program

Year:
2010
Language:
english
File:
PDF, 56 KB
english, 2010
104

How to integrate current knowledge in selecting patients for first line in NSCLC?

Year:
2010
Language:
english
File:
PDF, 54 KB
english, 2010
106

Developmental therapeutics

Year:
2010
Language:
english
File:
PDF, 360 KB
english, 2010
107

How to select targeted therapy in renal cell cancer

Year:
2010
Language:
english
File:
PDF, 53 KB
english, 2010
108

Circulating cancer cells

Year:
2010
Language:
english
File:
PDF, 72 KB
english, 2010
109

detection and diagnosis

Year:
2010
Language:
english
File:
PDF, 136 KB
english, 2010
111

posters A: Target identification and validation

Year:
2010
Language:
english
File:
PDF, 425 KB
english, 2010
113

Targeted therapies in soft tissue sarcomas

Year:
2010
Language:
english
File:
PDF, 60 KB
english, 2010
114

Neuroendocrine tumors

Year:
2010
Language:
english
File:
PDF, 116 KB
english, 2010
115

Special Symposium: Tailoring treatment of metastatic colorectal cancer

Year:
2010
Language:
english
File:
PDF, 38 KB
english, 2010
116

Cancer mortality trends in Spain: 1980-2007

Year:
2010
Language:
english
File:
PDF, 214 KB
english, 2010
117

Breast International Group (BIG)

Year:
2010
Language:
english
File:
PDF, 45 KB
english, 2010
118

Publication only

Year:
2010
Language:
english
File:
PDF, 560 KB
english, 2010
119

Symposium abstracts

Year:
2010
Language:
english
File:
PDF, 124 KB
english, 2010
120

The addition of new drugs to standard therapy in the first-line treatment of ovarian cancer

Year:
2010
Language:
english
File:
PDF, 77 KB
english, 2010
122

Biomarkers

Year:
2010
Language:
english
File:
PDF, 251 KB
english, 2010
123

Head and neck cancer

Year:
2010
Language:
english
File:
PDF, 245 KB
english, 2010
124

Acknowledgements

Year:
2010
Language:
english
File:
PDF, 18 KB
english, 2010
125

Cancer screening in Spain

Year:
2010
Language:
english
File:
PDF, 113 KB
english, 2010
126

Trends in principal cancer risk factors in Spain

Year:
2010
Language:
english
File:
PDF, 134 KB
english, 2010
127

Contact information

Year:
2010
File:
PDF, 10 KB
2010
128

plenary session 5: RNA-based approaches

Year:
2010
Language:
english
File:
PDF, 26 KB
english, 2010
133

Follicular lymphoma

Year:
2010
Language:
english
File:
PDF, 45 KB
english, 2010
134

Gastrointestinal neuroendocrine tumors

Year:
2010
Language:
english
File:
PDF, 392 KB
english, 2010
136

Do we have markers to select patients for adjuvant therapies of non-small-cell lung cancer?

Year:
2010
Language:
english
File:
PDF, 59 KB
english, 2010
137

Hematological malignancies

Year:
2010
Language:
english
File:
PDF, 216 KB
english, 2010
138

author index

Year:
2010
File:
PDF, 88 KB
2010
139

author index

Year:
2010
File:
PDF, 32 KB
2010
140

Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?

Year:
2010
Language:
english
File:
PDF, 50 KB
english, 2010
141

Prevention and screeninig

Year:
2010
Language:
english
File:
PDF, 55 KB
english, 2010
142

Special Symposium: MicroRNA's: The new genes involved in cancer

Year:
2010
Language:
english
File:
PDF, 33 KB
english, 2010
144

innovative trials design

Year:
2010
Language:
english
File:
PDF, 30 KB
english, 2010
145

Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer

Year:
2010
Language:
english
File:
PDF, 73 KB
english, 2010
147

ESMO/JSMO Joint Symposium: Biomarkers and selected therapeutics in lung and gastrointestinal cancer

Year:
2010
Language:
english
File:
PDF, 43 KB
english, 2010
148

Breast cancer, early

Year:
2010
Language:
english
File:
PDF, 284 KB
english, 2010
151

Posters

Year:
2010
Language:
english
File:
PDF, 2.24 MB
english, 2010
152

plenary session 2: Insulin-like growth factor receptor inhibitors

Year:
2010
Language:
english
File:
PDF, 38 KB
english, 2010
153

plenary session 9: Tyrosine Kinase drug targets

Year:
2010
Language:
english
File:
PDF, 64 KB
english, 2010
154

posters D: Apoptosis

Year:
2010
Language:
english
File:
PDF, 37 KB
english, 2010
155

the next wave of molecular therapies

Year:
2010
Language:
english
File:
PDF, 29 KB
english, 2010
156

molecular biology (pre-clinical)

Year:
2010
Language:
english
File:
PDF, 187 KB
english, 2010
157

subject index

Year:
2010
Language:
english
File:
PDF, 32 KB
english, 2010
161

Is there any role for surgery in the multidisciplinary treatment of esophageal cancer?

Year:
2010
Language:
english
File:
PDF, 53 KB
english, 2010
162

35th ESMO Congress travel grants

Year:
2010
Language:
english
File:
PDF, 17 KB
english, 2010
163

Special Symposium: Ovarian cancer: New biology, new targets

Year:
2010
Language:
english
File:
PDF, 39 KB
english, 2010
165

oral presentations

Year:
2010
Language:
english
File:
PDF, 179 KB
english, 2010
166

The impact of cancer in Spain: consequences for cancer prevention and care

Year:
2010
Language:
english
File:
PDF, 38 KB
english, 2010
167

Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications

Year:
2010
Language:
english
File:
PDF, 59 KB
english, 2010
169

posters

Year:
2010
Language:
english
File:
PDF, 1.31 MB
english, 2010
170

breast cancer initiation and metastatic progression

Year:
2010
Language:
english
File:
PDF, 34 KB
english, 2010
171

translational research terms reference list

Year:
2010
Language:
english
File:
PDF, 33 KB
english, 2010
173

Acknowledgements

Year:
2010
File:
PDF, 14 KB
2010
174

Introduction

Year:
2010
Language:
english
File:
PDF, 15 KB
english, 2010
175

Author index

Year:
2010
File:
PDF, 46 KB
2010
177

posters B: Drug design and synthesis

Year:
2010
Language:
english
File:
PDF, 146 KB
english, 2010
178

dna repair as a treatment target

Year:
2010
Language:
english
File:
PDF, 34 KB
english, 2010
179

is anti-angiogenic therapy dead in breast cancer?

Year:
2010
Language:
english
File:
PDF, 33 KB
english, 2010
180

adjuvant medical therapy

Year:
2010
Language:
english
File:
PDF, 128 KB
english, 2010
182

Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment

Year:
2010
Language:
english
File:
PDF, 93 KB
english, 2010
183

plenary session 12: Cell cycle targets

Year:
2010
Language:
english
File:
PDF, 38 KB
english, 2010
184

poster discussions

Year:
2010
Language:
english
File:
PDF, 198 KB
english, 2010
185

Chemotherapy: which drug and when?

Year:
2010
Language:
english
File:
PDF, 56 KB
english, 2010
186

Treatment of pT1N0 breast cancer: multigene predictors to assess risk of relapse

Year:
2010
Language:
english
File:
PDF, 60 KB
english, 2010
187

Special Symposium: Breast cancer challenges in the setting of curable disease

Year:
2010
Language:
english
File:
PDF, 37 KB
english, 2010
188

ESMO/ASCO Joint Symposium: The future of antiangiogenesis therapy

Year:
2010
Language:
english
File:
PDF, 35 KB
english, 2010
189

Basic science and translational research

Year:
2010
Language:
english
File:
PDF, 334 KB
english, 2010
190

Colorectal cancer

Year:
2010
Language:
english
File:
PDF, 556 KB
english, 2010
191

Oral session 1

Year:
2010
Language:
english
File:
PDF, 143 KB
english, 2010
194

Special Symposium: Overcoming disparities in cancer control in Europe

Year:
2010
Language:
english
File:
PDF, 35 KB
english, 2010
196

Young Oncologists

Year:
2010
Language:
english
File:
PDF, 17 KB
english, 2010
197

Genitourinary tumors

Year:
2010
Language:
english
File:
PDF, 461 KB
english, 2010
199

Oral presentations

Year:
2010
Language:
english
File:
PDF, 251 KB
english, 2010
200

Advances in the treatment of metastatic or unresectable biliary tract cancer

Year:
2010
Language:
english
File:
PDF, 77 KB
english, 2010
201

European Society for Medical Oncology Committees

Year:
2010
Language:
english
File:
PDF, 29 KB
english, 2010
202

plenary session 1: Opening ceremony

Year:
2010
Language:
english
File:
PDF, 21 KB
english, 2010
203

Gynecological cancer

Year:
2010
Language:
english
File:
PDF, 172 KB
english, 2010
204

What can the pathologist offer for optimal treatment choice?

Year:
2010
Language:
english
File:
PDF, 43 KB
english, 2010
205

European Organisation for Research and Treatment of Cancer (EORTC)

Year:
2010
Language:
english
File:
PDF, 37 KB
english, 2010
206

Special Symposium: Targeted agents in prostate cancer: Changing the paradigms

Year:
2010
Language:
english
File:
PDF, 38 KB
english, 2010
207

plenary session 6: Tumor microenvironment

Year:
2010
Language:
english
File:
PDF, 21 KB
english, 2010
208

ESMO Guidelines Working Group Disclosures

Year:
2010
Language:
english
File:
PDF, 26 KB
english, 2010
209

Should we continue to use the term non-small-cell lung cancer?

Year:
2010
Language:
english
File:
PDF, 62 KB
english, 2010
210

ESMO Foundation

Year:
2010
Language:
english
File:
PDF, 33 KB
english, 2010
211

ESMO/CSCO Joint Symposium: Personalised medicine: Do ethnic differences matter?

Year:
2010
Language:
english
File:
PDF, 36 KB
english, 2010
212

Sarcoma

Year:
2010
Language:
english
File:
PDF, 172 KB
english, 2010
214

Drug index

Year:
2010
Language:
english
File:
PDF, 41 KB
english, 2010
215

New trends for staging and therapy for localized gastroesophageal cancer: the role of PET

Year:
2010
Language:
english
File:
PDF, 255 KB
english, 2010
216

Proteomics as a guiding tool for more effective personalized therapy

Year:
2010
Language:
english
File:
PDF, 217 KB
english, 2010
217

ESMO Educational and Scientific activities

Year:
2010
Language:
english
File:
PDF, 24 KB
english, 2010
218

Breast cancer, advanced

Year:
2010
Language:
english
File:
PDF, 413 KB
english, 2010
219

ESMO DCTF/UICC/WHO Joint Symposium: Meeting the challenge of managing cervical cancer in the developing world

Year:
2010
Language:
english
File:
PDF, 32 KB
english, 2010
220

posters F: Phase 1 and 2 studies

Year:
2010
Language:
english
File:
PDF, 67 KB
english, 2010
221

35th ESMO Congress Organization

Year:
2010
Language:
english
File:
PDF, 85 KB
english, 2010
222

Author index

Year:
2010
File:
PDF, 227 KB
2010
223

plenary session 11: Apoptotic and nuclear targets

Year:
2010
Language:
english
File:
PDF, 67 KB
english, 2010
224

Special Symposium: Emerging concepts in head and neck cancer diagnostics and therapy

Year:
2010
Language:
english
File:
PDF, 40 KB
english, 2010
225

Gastrointestinal tumors (upper)

Year:
2010
Language:
english
File:
PDF, 239 KB
english, 2010
226

Multiple myeloma

Year:
2010
Language:
english
File:
PDF, 93 KB
english, 2010
227

Multimodality treatment for localized gastro-oesophageal cancer

Year:
2010
Language:
english
File:
PDF, 89 KB
english, 2010
228

posters E: Biomarkers

Year:
2010
Language:
english
File:
PDF, 188 KB
english, 2010
229

ESMO-MORA

Year:
2010
Language:
english
File:
PDF, 29 KB
english, 2010
231

Plenary session

Year:
2010
Language:
english
File:
PDF, 78 KB
english, 2010
232

IMPAKT 2010 Breast Cancer Conference Officers

Year:
2010
Language:
english
File:
PDF, 31 KB
english, 2010
233

Cardiotoxicity

Year:
2010
Language:
english
File:
PDF, 87 KB
english, 2010
234

Mesothelioma

Year:
2010
Language:
english
File:
PDF, 87 KB
english, 2010
235

Subject index

Year:
2010
Language:
english
File:
PDF, 107 KB
english, 2010
236

How to integrate molecular targeted agents in the continuum of care

Year:
2010
Language:
english
File:
PDF, 72 KB
english, 2010
237

Foundation "St.Gallen Oncology Conferences" (SONK)

Year:
2010
Language:
english
File:
PDF, 28 KB
english, 2010